Eric Siemers
Eli Lilly (United States)
2 papers in the Anchorcite directory, published between 2011 and 2018, cited 18,284 times in total.
ORCID profileResearch topics
- Alzheimer's disease research and treatments · 2 papers
- Dementia and Cognitive Impairment Research · 2 papers
- Health, Environment, Cognitive Aging · 1 paper
- Cholinesterase and Neurodegenerative Diseases · 1 paper
Frequent co-authors
- Clifford R. Jack · 2 papers
- David Alan Bennett · 2 papers
- María C. Carrillo · 2 papers
- Thomas J. Montine · 2 papers
- Creighton H. Phelps · 2 papers
- Christopher Cleon Rowe · 2 papers
- Reisa Anne Sperling · 2 papers
- Kaj Blennow · 1 paper
Papers
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer s & Dementia · 2018 · 10,970 citations
In 2011, the National Institute on Aging and Alzheimer's Association created separate diagnostic recommendations for the preclinical, mild cognitive impairment, and dementia stages of Alzheimer's disease. Scientific progress in the interim led to an initiative by the National Institute on…
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer s & Dementia · 2011 · 7,314 citations
The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the diagnosis of AD dementia. This long "preclinical" phase of AD would provide a critical opportunity for therapeutic intervention; however, we need to further elucidate the…
Metadata from OpenAlex (CC0).